- Home
- GGG vs PCVX Comparison
GGG vs PCVX Comparison
Compare GGG & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GGG
- PCVX
- Stock Information
- Founded
- GGG 1926
- PCVX 2013
- Country
- GGG United States
- PCVX United States
- Employees
- GGG N/A
- PCVX N/A
- Industry
- GGG Fluid Controls
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- GGG Industrials
- PCVX Health Care
- Exchange
- GGG Nasdaq
- PCVX Nasdaq
- Market Cap
- GGG 14.2B
- PCVX 13.2B
- IPO Year
- GGG N/A
- PCVX 2020
- Fundamental
- Price
- GGG $85.15
- PCVX $85.30
- Analyst Decision
- GGG Hold
- PCVX Strong Buy
- Analyst Count
- GGG 3
- PCVX 9
- Target Price
- GGG $87.00
- PCVX $149.38
- AVG Volume (30 Days)
- GGG 685.7K
- PCVX 1.2M
- Earning Date
- GGG 01-27-2025
- PCVX 02-25-2025
- Dividend Yield
- GGG 1.22%
- PCVX N/A
- EPS Growth
- GGG N/A
- PCVX N/A
- EPS
- GGG 2.83
- PCVX N/A
- Revenue
- GGG $2,131,288,000.00
- PCVX N/A
- Revenue This Year
- GGG N/A
- PCVX N/A
- Revenue Next Year
- GGG $4.76
- PCVX N/A
- P/E Ratio
- GGG $30.09
- PCVX N/A
- Revenue Growth
- GGG N/A
- PCVX N/A
- 52 Week Low
- GGG $77.49
- PCVX $58.10
- 52 Week High
- GGG $94.77
- PCVX $121.06
- Technical
- Relative Strength Index (RSI)
- GGG 52.03
- PCVX 48.31
- Support Level
- GGG $80.30
- PCVX $77.52
- Resistance Level
- GGG $85.00
- PCVX $89.65
- Average True Range (ATR)
- GGG 1.40
- PCVX 3.95
- MACD
- GGG 0.34
- PCVX 0.77
- Stochastic Oscillator
- GGG 88.34
- PCVX 62.04
About GGG Graco Inc.
Graco manufactures equipment used for managing fluids, coatings, and adhesives, specializing in difficult-to-handle materials. Graco's business is organized into three segments: industrial, process, and contractor. The Minnesota-based firm serves a wide range of end markets, including industrial, automotive, and construction, and its broad array of products include pumps, valves, meters, sprayers, and equipment used to apply coatings, sealants, and adhesives. The firm generated roughly $2.2 billion in sales in 2023.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-24, VAX-A1, and VAX-PG.